Mindmed appoints schond l. greenway as chief financial officer

New york , may 23, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed) (the "company" or "mindmed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced the appointment of schond l. greenway as chief financial officer.
MNMD Ratings Summary
MNMD Quant Ranking